Polyps Market 2018 Competitive Analysis - Medtronic, Cook Medical, Endo Pharmaceuticals Inc, Pfizer Inc, Teva Pharma and More

The Global Polyps Market is expected to reach US$ 18.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 9.2 % during the forecast period 2017-2023.

A polyp is an abnormal growth of tissue projecting from a mucous membrane commonly found in the colon, stomach, nose, ear, sinus, urinary bladder, uterus etc. although they may occur elsewhere in the body where mucous membranes exist. Most polyps are benign or non-cancerous while a few are premalignant.

Premalignant polyps can be a trigger factors for cancer and in general, the larger a polyp, the greater the risk of cancer, especially with pre-malignant polyps. Most polyps have no symptoms and screening is the only reliable measure to detect them. Symptoms when evident are irregular periods and vaginal bleeding in women, dysmenorrhea, pain, diarrhoea, constipation, nausea, vomiting etc. depending on the location of the polyp.

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/4176 .

Screening is the most important driver for the global polyp market. The U.S. Department of Health and Human Services estimates that in 2016, an estimated 134,490 people in the United States were diagnosed with colorectal cancer and 49,190 people died from contracting it.

The market drivers for polyp market are increasing geriatric population, growing screening, rising awareness, cancer causing potential of polyps etc. The market restraints are risks such as bleeding and infection during surgery, low healthcare expenditure in developing regions, costs considerations especially for minimally invasive surgeries, no symptoms of most polyps, personal or family history of polyps etc.

Global Polyps Market Players

Key players profiled in the report are Millennium Surgical Corp, Black Smith Surgical, B. Braun Melsungen AG, Medtronic, Cook Medical, Endo Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan Inc., Sun Pharmaceuticals and others.

Regional analysis:

The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global polyps market. Also, concentration of major research companies and cancer research sector in the developed countries of this region is adding fuel to the market growth.

Europe is the second largest market in the world due to high income and healthcare penetration.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/4176 .

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Brief TOC

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5 Market Factor analysis

…TOC Continued

Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/4176 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.